Expression of ICAM-1, HLA-DR, and CD80 on peripheral circulating CD1 α DCs induced in vivo by IFN-α in patients with chronic hepatitis B
Authors:
- Yong-Sheng YuYYYong-Sheng Yu
- Zheng-Hao TangZTZheng-Hao Tang
- Jing-Chao HanJHJing-Chao Han
- Min XiMXMin Xi
- Jie FengJFJie Feng
- Guo-Qing ZangGZGuo-Qing Zang
Open Access
- 1 January 2006
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (9) , 1447-1451
Abstract
AIM: To explore the effects of interferon-α (IFN-α) application on peripheral circulating CD1α dendritic cells (DCs) in patients with chronic hepatitis B, and the expression of HLA-DR, CD80, and ICAM-1 on CD1α DCs in order to explore the mechanism of immune modulation of IFN-α. METHODS: By flow cytometry technique, changes of CD1α DCs were monitored in 22 patients with chronic hepatitis B treated with IFN-α and in 16 such patients not treated with IFN-α within three months. Meanwhile, the expression of HLA-DR, CD80, and ICAM-1 on CD1α DCs was detected. RESULTS: In the group of IFN-α treatment, the percentage of CD1α DCs in peripheral blood mononuclear cells was increased after three months of therapy. In patients who became negative for HBV-DNA after IFN-α treatment, the increase of DCs was more prominent, while in control, these changes were not observed. Increased expression of HLA-DR, CD80, and ICAM-1 on CD1α DCs was also observed. CONCLUSION: CD1α DCs can be induced by IFN-α in vivo, and the immune related molecules such as HLA-DR, CD80, and ICAM-1 are up-regulated to some degree. This might be an important immune related mechanism of IFN-α treatment for chronic hepatitis B.Keywords
This publication has 30 references indexed in Scilit:
- Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2)Journal of Gastroenterology and Hepatology, 2005
- Decreased Frequency and Function of Circulating Plasmocytoid Dendritic Cells (pDC) in Hepatitis B Virus Infected HumansJournal of Clinical Immunology, 2004
- Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis BHepatology, 2004
- Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease†Hepatology, 2004
- Safety and efficacy of hepatitis B surface antigen-pulsed dendritic cells in human volunteersHepatology Research, 2004
- Selective functional deficit in dendritic cell – T cell interaction is a crucial mechanism in chronic hepatitis B virus infectionJournal of Viral Hepatitis, 2004
- Low dose daily rhGM–CSF application activates monocytes and dendritic cells in vivoLeukemia Research, 2003
- Interferon‐α disables dendritic cell precursors: dendritic cells derived from interferon‐α‐treated monocytes are defective in maturation and T‐cell stimulationImmunology, 2003
- Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cellsJournal of Clinical Investigation, 1999
- Prognostic importance of antigen‐presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrierImmunology, 1999